Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 8 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0009331 | glycerol-3-phosphate dehydrogenase complex | 4 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:1902494 | catalytic complex | 2 | 1 |
GO:1990204 | oxidoreductase complex | 3 | 1 |
Related structures:
AlphaFold database: E9AE85
Term | Name | Level | Count |
---|---|---|---|
GO:0006072 | glycerol-3-phosphate metabolic process | 5 | 2 |
GO:0006793 | phosphorus metabolic process | 3 | 2 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009056 | catabolic process | 2 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0019637 | organophosphate metabolic process | 3 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0046168 | glycerol-3-phosphate catabolic process | 5 | 2 |
GO:0046434 | organophosphate catabolic process | 4 | 2 |
GO:0052646 | alditol phosphate metabolic process | 4 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:1901135 | carbohydrate derivative metabolic process | 3 | 2 |
GO:1901136 | carbohydrate derivative catabolic process | 4 | 2 |
GO:1901575 | organic substance catabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 2 |
GO:0003824 | catalytic activity | 1 | 2 |
GO:0005488 | binding | 1 | 2 |
GO:0016491 | oxidoreductase activity | 2 | 2 |
GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 3 | 2 |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 4 | 2 |
GO:0036094 | small molecule binding | 2 | 2 |
GO:0047952 | glycerol-3-phosphate dehydrogenase [NAD(P)+] activity | 5 | 1 |
GO:0051287 | NAD binding | 4 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:1901265 | nucleoside phosphate binding | 3 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 265 | 269 | PF00656 | 0.634 |
CLV_C14_Caspase3-7 | 333 | 337 | PF00656 | 0.545 |
CLV_NRD_NRD_1 | 111 | 113 | PF00675 | 0.415 |
CLV_NRD_NRD_1 | 2 | 4 | PF00675 | 0.522 |
CLV_NRD_NRD_1 | 420 | 422 | PF00675 | 0.563 |
CLV_NRD_NRD_1 | 427 | 429 | PF00675 | 0.548 |
CLV_PCSK_KEX2_1 | 113 | 115 | PF00082 | 0.425 |
CLV_PCSK_KEX2_1 | 2 | 4 | PF00082 | 0.599 |
CLV_PCSK_PC1ET2_1 | 113 | 115 | PF00082 | 0.425 |
CLV_PCSK_SKI1_1 | 137 | 141 | PF00082 | 0.523 |
CLV_PCSK_SKI1_1 | 277 | 281 | PF00082 | 0.606 |
CLV_PCSK_SKI1_1 | 321 | 325 | PF00082 | 0.490 |
CLV_PCSK_SKI1_1 | 530 | 534 | PF00082 | 0.480 |
CLV_PCSK_SKI1_1 | 8 | 12 | PF00082 | 0.442 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.636 |
DEG_SCF_FBW7_1 | 121 | 127 | PF00400 | 0.438 |
DEG_SCF_FBW7_1 | 235 | 242 | PF00400 | 0.530 |
DEG_SCF_FBW7_1 | 85 | 92 | PF00400 | 0.506 |
DOC_CKS1_1 | 121 | 126 | PF01111 | 0.476 |
DOC_CKS1_1 | 217 | 222 | PF01111 | 0.584 |
DOC_CKS1_1 | 236 | 241 | PF01111 | 0.452 |
DOC_MAPK_gen_1 | 112 | 121 | PF00069 | 0.393 |
DOC_PP1_RVXF_1 | 28 | 35 | PF00149 | 0.319 |
DOC_PP1_RVXF_1 | 319 | 325 | PF00149 | 0.445 |
DOC_PP1_RVXF_1 | 419 | 426 | PF00149 | 0.611 |
DOC_PP2B_LxvP_1 | 332 | 335 | PF13499 | 0.456 |
DOC_PP2B_LxvP_1 | 397 | 400 | PF13499 | 0.426 |
DOC_USP7_MATH_1 | 124 | 128 | PF00917 | 0.512 |
DOC_USP7_MATH_1 | 161 | 165 | PF00917 | 0.658 |
DOC_USP7_MATH_1 | 239 | 243 | PF00917 | 0.522 |
DOC_USP7_MATH_1 | 252 | 256 | PF00917 | 0.694 |
DOC_USP7_MATH_1 | 279 | 283 | PF00917 | 0.709 |
DOC_USP7_MATH_1 | 28 | 32 | PF00917 | 0.516 |
DOC_USP7_MATH_1 | 325 | 329 | PF00917 | 0.548 |
DOC_USP7_MATH_1 | 349 | 353 | PF00917 | 0.371 |
DOC_USP7_MATH_1 | 400 | 404 | PF00917 | 0.408 |
DOC_USP7_MATH_1 | 68 | 72 | PF00917 | 0.731 |
DOC_USP7_MATH_1 | 73 | 77 | PF00917 | 0.695 |
DOC_USP7_MATH_1 | 80 | 84 | PF00917 | 0.595 |
DOC_USP7_MATH_1 | 89 | 93 | PF00917 | 0.540 |
DOC_WW_Pin1_4 | 120 | 125 | PF00397 | 0.424 |
DOC_WW_Pin1_4 | 216 | 221 | PF00397 | 0.589 |
DOC_WW_Pin1_4 | 235 | 240 | PF00397 | 0.481 |
DOC_WW_Pin1_4 | 248 | 253 | PF00397 | 0.671 |
DOC_WW_Pin1_4 | 300 | 305 | PF00397 | 0.468 |
DOC_WW_Pin1_4 | 392 | 397 | PF00397 | 0.407 |
DOC_WW_Pin1_4 | 460 | 465 | PF00397 | 0.393 |
DOC_WW_Pin1_4 | 75 | 80 | PF00397 | 0.687 |
DOC_WW_Pin1_4 | 85 | 90 | PF00397 | 0.593 |
LIG_14-3-3_CanoR_1 | 154 | 159 | PF00244 | 0.508 |
LIG_14-3-3_CanoR_1 | 523 | 531 | PF00244 | 0.461 |
LIG_14-3-3_CanoR_1 | 8 | 13 | PF00244 | 0.372 |
LIG_BRCT_BRCA1_1 | 30 | 34 | PF00533 | 0.340 |
LIG_BRCT_BRCA1_1 | 413 | 417 | PF00533 | 0.434 |
LIG_CtBP_PxDLS_1 | 4 | 8 | PF00389 | 0.458 |
LIG_deltaCOP1_diTrp_1 | 133 | 140 | PF00928 | 0.487 |
LIG_FHA_1 | 146 | 152 | PF00498 | 0.431 |
LIG_FHA_1 | 217 | 223 | PF00498 | 0.448 |
LIG_FHA_1 | 301 | 307 | PF00498 | 0.432 |
LIG_FHA_1 | 379 | 385 | PF00498 | 0.332 |
LIG_FHA_1 | 408 | 414 | PF00498 | 0.488 |
LIG_FHA_1 | 49 | 55 | PF00498 | 0.616 |
LIG_FHA_1 | 7 | 13 | PF00498 | 0.523 |
LIG_FHA_2 | 263 | 269 | PF00498 | 0.517 |
LIG_FHA_2 | 331 | 337 | PF00498 | 0.532 |
LIG_FHA_2 | 495 | 501 | PF00498 | 0.571 |
LIG_FHA_2 | 508 | 514 | PF00498 | 0.569 |
LIG_LIR_Gen_1 | 31 | 42 | PF02991 | 0.331 |
LIG_LIR_Gen_1 | 463 | 473 | PF02991 | 0.380 |
LIG_LIR_Nem_3 | 31 | 37 | PF02991 | 0.303 |
LIG_LIR_Nem_3 | 463 | 469 | PF02991 | 0.362 |
LIG_LIR_Nem_3 | 489 | 494 | PF02991 | 0.616 |
LIG_LIR_Nem_3 | 88 | 93 | PF02991 | 0.573 |
LIG_PDZ_Class_1 | 535 | 540 | PF00595 | 0.581 |
LIG_Pex14_2 | 175 | 179 | PF04695 | 0.409 |
LIG_SH2_SRC | 128 | 131 | PF00017 | 0.378 |
LIG_SH2_STAP1 | 373 | 377 | PF00017 | 0.467 |
LIG_SH2_STAP1 | 466 | 470 | PF00017 | 0.344 |
LIG_SH2_STAT5 | 128 | 131 | PF00017 | 0.499 |
LIG_SH2_STAT5 | 331 | 334 | PF00017 | 0.469 |
LIG_SH2_STAT5 | 362 | 365 | PF00017 | 0.627 |
LIG_SH2_STAT5 | 426 | 429 | PF00017 | 0.632 |
LIG_SH3_3 | 251 | 257 | PF00018 | 0.691 |
LIG_SH3_3 | 458 | 464 | PF00018 | 0.497 |
LIG_SH3_3 | 76 | 82 | PF00018 | 0.666 |
LIG_SUMO_SIM_anti_2 | 33 | 39 | PF11976 | 0.545 |
LIG_SUMO_SIM_par_1 | 218 | 225 | PF11976 | 0.470 |
LIG_SxIP_EBH_1 | 246 | 256 | PF03271 | 0.679 |
LIG_TRAF2_2 | 190 | 195 | PF00917 | 0.378 |
LIG_WRC_WIRS_1 | 350 | 355 | PF05994 | 0.478 |
MOD_CK1_1 | 164 | 170 | PF00069 | 0.684 |
MOD_CK1_1 | 234 | 240 | PF00069 | 0.611 |
MOD_CK1_1 | 243 | 249 | PF00069 | 0.652 |
MOD_CK1_1 | 259 | 265 | PF00069 | 0.759 |
MOD_CK1_1 | 360 | 366 | PF00069 | 0.510 |
MOD_CK1_1 | 56 | 62 | PF00069 | 0.721 |
MOD_CK1_1 | 83 | 89 | PF00069 | 0.552 |
MOD_CK2_1 | 210 | 216 | PF00069 | 0.625 |
MOD_CK2_1 | 281 | 287 | PF00069 | 0.554 |
MOD_CK2_1 | 494 | 500 | PF00069 | 0.556 |
MOD_CK2_1 | 515 | 521 | PF00069 | 0.524 |
MOD_CK2_1 | 63 | 69 | PF00069 | 0.594 |
MOD_Cter_Amidation | 419 | 422 | PF01082 | 0.589 |
MOD_GlcNHglycan | 107 | 110 | PF01048 | 0.659 |
MOD_GlcNHglycan | 156 | 159 | PF01048 | 0.476 |
MOD_GlcNHglycan | 207 | 210 | PF01048 | 0.666 |
MOD_GlcNHglycan | 224 | 227 | PF01048 | 0.348 |
MOD_GlcNHglycan | 242 | 245 | PF01048 | 0.528 |
MOD_GlcNHglycan | 258 | 261 | PF01048 | 0.678 |
MOD_GlcNHglycan | 281 | 284 | PF01048 | 0.662 |
MOD_GlcNHglycan | 292 | 295 | PF01048 | 0.393 |
MOD_GlcNHglycan | 458 | 461 | PF01048 | 0.431 |
MOD_GlcNHglycan | 500 | 504 | PF01048 | 0.641 |
MOD_GlcNHglycan | 517 | 520 | PF01048 | 0.440 |
MOD_GlcNHglycan | 58 | 61 | PF01048 | 0.707 |
MOD_GlcNHglycan | 65 | 68 | PF01048 | 0.755 |
MOD_GlcNHglycan | 71 | 74 | PF01048 | 0.604 |
MOD_GSK3_1 | 120 | 127 | PF00069 | 0.489 |
MOD_GSK3_1 | 150 | 157 | PF00069 | 0.502 |
MOD_GSK3_1 | 212 | 219 | PF00069 | 0.542 |
MOD_GSK3_1 | 231 | 238 | PF00069 | 0.478 |
MOD_GSK3_1 | 239 | 246 | PF00069 | 0.598 |
MOD_GSK3_1 | 248 | 255 | PF00069 | 0.533 |
MOD_GSK3_1 | 269 | 276 | PF00069 | 0.721 |
MOD_GSK3_1 | 298 | 305 | PF00069 | 0.411 |
MOD_GSK3_1 | 356 | 363 | PF00069 | 0.430 |
MOD_GSK3_1 | 407 | 414 | PF00069 | 0.403 |
MOD_GSK3_1 | 456 | 463 | PF00069 | 0.421 |
MOD_GSK3_1 | 69 | 76 | PF00069 | 0.771 |
MOD_GSK3_1 | 81 | 88 | PF00069 | 0.610 |
MOD_N-GLC_1 | 28 | 33 | PF02516 | 0.469 |
MOD_N-GLC_1 | 63 | 68 | PF02516 | 0.554 |
MOD_N-GLC_2 | 345 | 347 | PF02516 | 0.333 |
MOD_NEK2_1 | 222 | 227 | PF00069 | 0.554 |
MOD_NEK2_1 | 240 | 245 | PF00069 | 0.505 |
MOD_NEK2_1 | 357 | 362 | PF00069 | 0.513 |
MOD_NEK2_1 | 456 | 461 | PF00069 | 0.427 |
MOD_NEK2_1 | 469 | 474 | PF00069 | 0.373 |
MOD_NEK2_1 | 535 | 540 | PF00069 | 0.552 |
MOD_PKA_2 | 325 | 331 | PF00069 | 0.424 |
MOD_PKA_2 | 477 | 483 | PF00069 | 0.506 |
MOD_PKA_2 | 494 | 500 | PF00069 | 0.402 |
MOD_PKA_2 | 522 | 528 | PF00069 | 0.615 |
MOD_Plk_1 | 231 | 237 | PF00069 | 0.446 |
MOD_Plk_1 | 28 | 34 | PF00069 | 0.567 |
MOD_Plk_4 | 124 | 130 | PF00069 | 0.470 |
MOD_Plk_4 | 327 | 333 | PF00069 | 0.410 |
MOD_Plk_4 | 33 | 39 | PF00069 | 0.455 |
MOD_Plk_4 | 357 | 363 | PF00069 | 0.548 |
MOD_Plk_4 | 401 | 407 | PF00069 | 0.425 |
MOD_Plk_4 | 472 | 478 | PF00069 | 0.428 |
MOD_Plk_4 | 53 | 59 | PF00069 | 0.638 |
MOD_Plk_4 | 8 | 14 | PF00069 | 0.492 |
MOD_Plk_4 | 89 | 95 | PF00069 | 0.466 |
MOD_ProDKin_1 | 120 | 126 | PF00069 | 0.424 |
MOD_ProDKin_1 | 216 | 222 | PF00069 | 0.579 |
MOD_ProDKin_1 | 235 | 241 | PF00069 | 0.490 |
MOD_ProDKin_1 | 248 | 254 | PF00069 | 0.671 |
MOD_ProDKin_1 | 300 | 306 | PF00069 | 0.468 |
MOD_ProDKin_1 | 392 | 398 | PF00069 | 0.401 |
MOD_ProDKin_1 | 460 | 466 | PF00069 | 0.385 |
MOD_ProDKin_1 | 75 | 81 | PF00069 | 0.685 |
MOD_ProDKin_1 | 85 | 91 | PF00069 | 0.578 |
MOD_SUMO_rev_2 | 92 | 102 | PF00179 | 0.483 |
TRG_DiLeu_BaEn_1 | 218 | 223 | PF01217 | 0.433 |
TRG_DiLeu_BaEn_1 | 501 | 506 | PF01217 | 0.523 |
TRG_ENDOCYTIC_2 | 466 | 469 | PF00928 | 0.349 |
TRG_ENDOCYTIC_2 | 473 | 476 | PF00928 | 0.392 |
TRG_ER_diArg_1 | 1 | 3 | PF00400 | 0.685 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P658 | Leptomonas seymouri | 54% | 100% |
A0A0S4ITH1 | Bodo saltans | 24% | 100% |
A0A3Q8IFB4 | Leishmania donovani | 93% | 100% |
A0A422NEK6 | Trypanosoma rangeli | 33% | 100% |
A4HHM3 | Leishmania braziliensis | 79% | 100% |
A4I4T2 | Leishmania infantum | 93% | 93% |
C9ZLH9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 39% | 100% |
E9ALK0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |